Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.760
+0.070 (1.90%)
At close: Feb 13, 2026

Revenue by Product

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Innovative Drugs
77.92M
Innovative Drugs Growth
5.82%

Revenue by Geography

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
China
77.92M
China Growth
5.82%